Turnover Within CRO Companies Remains Persistently High


Applied Clinical Trials

CRO companies are battling high turnover levels, but a new report from BDO USA, LLP, finds that compensation strategies generally have not made enough adjustments to their compensation strategy to address this on going issue. This report examines compensation and benefits trends in the CRO industry over the last 10 years, with a special focus on clinical research associates. 

Read the full release here.

Recent Videos
Related Content
© 2024 MJH Life Sciences

All rights reserved.